EN
登录

MGI Tech收购STOmics和CycloneSEQ,以推进空间生物学和纳米孔测序技术的发展

MGI Tech aquires STOmics and CycloneSEQ to advance spatial biology and nanopore sequencing technologies

BioSpectrum Asia 等信源发布 2026-03-04 14:57

可切换为仅中文


To deliver integrated short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies

提供整合的短读长测序、长读长纳米孔测序、生成式实验室智能和空间组学技术

MGI Tech Co., Ltd. , a company dedicated to developing core tools and technologies that drive innovation in the life sciences, announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's 'SEQALL+GLI+Omics' strategy, positioning the company as the world's only manufacturer of core life science tools spanning short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies..

华大智造科技股份有限公司致力于开发生命科学领域的核心工具和技术,推动生命科学创新,公司宣布收购STOmics和CycloneSEQ。这标志着华大智造“SEQALL+GLI+Omics”战略的一个重要里程碑,使其成为全球唯一一家覆盖短读长测序、长读长纳米孔测序、生成式实验室智能以及空间组学技术等核心生命科学工具的制造商。

By bringing spatial biology and nanopore sequencing technologies fully in house, MGI strengthens its product portfolio, enhances long-term competitiveness and advances its vision of becoming a one-stop solution provider for customers' long-read and short-read sequencing needs.

通过将空间生物学和纳米孔测序技术完全纳入公司内部,MGI加强了其产品组合,提升了长期竞争力,并推进了其成为客户长读和短读测序需求的一站式解决方案提供商的愿景。

Advancing Spatial Multi-Omics with STOmics

利用STOmics推进空间多组学发展

Established in April 2024, STOmics' proprietary Stereo-seq technology represents a breakthrough in spatial multi-omics, featuring:

成立于2024年4月,STOmics的专有Stereo-seq技术代表了空间多组学领域的突破,其特点包括:

Large field of view

大视场

Nano-scale resolution

纳米级分辨率

Unbiased whole-transcriptome capture

无偏全转录组捕获

Integrated multi-omics solutions

整合的多组学解决方案

The technology has been widely applied in developmental biology, organ atlas mapping, neuroscience, and digital pathology. To date, Stereo-seq has contributed to more than 60 publications in leading scientific journals, including Cell, Science, Nature, and Cell Research.

该技术已广泛应用于发育生物学、器官图谱绘制、神经科学和数字病理学。截至目前,Stereo-seq 已助力发表在 Cell、Science、Nature 和 Cell Research 等顶级科学期刊上的 60 多篇论文。

STOmics' solutions are highly compatible with MGI's patented DNBSEQ sequencing platform, for instance, Stereo-seq libraries are sequenced using MGI's flagship G400 and T7 platforms, ensuring high-quality data output.

STOmics的解决方案与MGI专利的DNBSEQ测序平台高度兼容,例如,Stereo-seq文库使用MGI的旗舰G400和T7平台进行测序,确保高质量的数据输出。

Following the acquisition, MGI can now offer more accessible, comprehensive, and efficient spatial-temporal omics

收购后,MGI现在可以提供更易获取、更全面、更高效的时空组学技术。

workflow solutions—empowering researchers with deeper, three-dimensional insights into biological processes.

工作流程解决方案——赋予研究人员更深入、三维的生物过程洞察力。

Expanding Long-Read Capabilities with CycloneSEQ

扩展长读取能力与CycloneSEQ

CycloneSEQ, established in March 2024, has commercialized nanopore sequencing technology as two platforms: G100-ER* for lower throughput and G400-ER* for higher throughput. What is worth mentioning, G100-ER* has obtained CE marking under the European Union's In Vitro Diagnostic Regulation (IVDR), reinforcing its compliance and readiness for regulated markets..

CycloneSEQ 于 2024 年 3 月成立,已将纳米孔测序技术商业化为两个平台:G100-ER* 适用于较低通量,G400-ER* 适用于较高通量。值得一提的是,G100-ER* 已获得欧盟体外诊断法规 (IVDR) 的 CE 标志,进一步巩固了其在受监管市场的合规性和适用性。

MGI's DNBSEQ technology, which delivers high throughput, high accuracy and cost-effectiveness, naturally complements CycloneSEQ's long-read nanopore sequencing capabilities. Through this integration, MGI will provide users with a comprehensive 'long-read + short-read' sequencing toolkit.

MGI的DNBSEQ技术具备高通量、高准确性和成本效益,自然与CycloneSEQ的长读长纳米孔测序能力形成互补。通过此次整合,MGI将为用户提供一套全面的“长读长+短读长”测序工具包。

Delivering a True 'SEQALL+GLI+Omics' One-Stop

提供真正的“SEQALL+GLI+Omics”一站式服务

Both STOmics and CycloneSEQ have already maintained close collaboration with MGI, with MGI holding exclusive global distribution licenses for their reagents and products.

STOmics和CycloneSEQ均已与MGI保持密切合作,MGI拥有其试剂和产品的全球独家经销权。

Upon completion of integration and combination of short-read, long-read and spatial omics under one provider, along with existing generative lab intelligence, MGI significantly enhances customer service capabilities, operational efficiency, and long-term partnership value through the 'SEQALL+GLI+Omics' strategy..

通过“SEQALL+GLI+多组学”战略,在一家供应商内完成短读、长读和空间多组学的整合与结合,并利用现有的生成型实验室智能,MGI显著提升了客户服务能力、运营效率以及长期合作价值。

*This information is for general reference only and does not imply that the relevant product or service will be available in any specific country or region.

*此信息仅供参考,不意味着相关产品或服务会在任何特定国家或地区提供。